When drugmaker AstraZeneca closed down its research and development centre in Bangalore six years ago, some of the local scientists managed to find new jobs at a nearby biotech start-up. Since then, they have been working to tackle a problem which is causing concern among doctors in India and around the world: the human body’s increasing resistance to antibiotics.
6年前，當製藥商阿斯特捷利康(AstraZeneca)關閉在邦加羅爾的研發中心後，一些當地科學家設法在附近的一家生物科技新創企業找到新的工作。自那以來，他們一直致力於對付一個正在引起印度乃至世界各地醫生擔憂的問題：人體對抗生素日益增強的耐藥性。
您已閱讀4%（486字），剩餘96%（11085字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。